24-Norursodeoxycholic acid ameliorates experimental alcohol-related liver disease and activates hepatic PPARγ
Christoph Grander(Innsbruck Medical University), Herbert Tilg(Innsbruck Medical University), Bela Hausmann(Medical University of Vienna), Felix Grabherr(Innsbruck Medical University), Daniel Steinacher(Medical University of Vienna), Timon E. Adolph(Innsbruck Medical University), Julian Schwärzler(Innsbruck Medical University), Almina Jukic(Innsbruck Medical University), Manuel Grander(Innsbruck Medical University), Petra Pjevac(University of Vienna), Thierry Claudel(Medical University of Vienna), Natascha Brigo(Innsbruck Medical University), Michael Trauner(Medical University of Graz), Georg Oberhuber(Innsbruck Medical University), Moritz Meyer(Innsbruck Medical University), Günter Weiß(Innsbruck Medical University)
Cited by 8
Related Papers
Evolution of Inflammation in Nonalcoholic Fatty Liver Disease: The Multiple Parallel Hits Hypothesis
|Hepatology|2010|2.4k
A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis
|New England Journal of Medicine|2016|1.1k
Macrophage defense mechanisms against intracellular bacteria
|Immunological Reviews|2015|975
Visfatin, an Adipocytokine with Proinflammatory and Immunomodulating Properties
|The Journal of Immunology|2007|915
Inflammatory Mechanisms in the Regulation of Insulin Resistance
|Molecular Medicine|2008|762